Medicare to Extend Coverage for FDA Fully-Approved Alzheimer’s Drugs, With Conditions
Medicare announces coverage expansion for Alzheimer’s drugs pending full FDA approval, subject to certain limitations. TWC – In a groundbreaking move, Medicare is set to broaden its coverage to include a new class of Alzheimer’s drugs, provided they receive complete approval from the U.S. Food and Drug Administration (FDA), albeit with certain restrictions. The U.S. […]